Home > Qtrly Results > DIVIS LABORATORIES

DIVIS LABORATORIES
Quarterly Results Analysis [Sep2026]

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹3,676 Cr ₹3,080 Cr ₹2,831 Cr ₹2,604 Cr ₹2,715 Cr ₹2,410 Cr ₹2,585 Cr ₹2,319 Cr
Expenses ₹2,110 Cr ₹1,825 Cr ₹1,897 Cr ₹1,714 Cr ₹1,827 Cr ₹1,681 Cr ₹1,699 Cr ₹1,576 Cr
Operating Income ₹1,566 Cr ₹1,255 Cr ₹934 Cr ₹890 Cr ₹888 Cr ₹729 Cr ₹886 Cr ₹743 Cr
Other Income ₹94 Cr ₹64 Cr ₹155 Cr ₹88 Cr ₹145 Cr ₹119 Cr ₹86 Cr ₹82 Cr
Interest ₹13 Cr ₹6 Cr ₹6 Cr ₹6 Cr ₹8 Cr ₹3 Cr ₹1 Cr ₹0 Cr
Depreciation ₹142 Cr ₹133 Cr ₹120 Cr ₹118 Cr ₹113 Cr ₹112 Cr ₹107 Cr ₹99 Cr
Profit Before Tax ₹1,505 Cr ₹1,180 Cr ₹963 Cr ₹780 Cr ₹912 Cr ₹733 Cr ₹864 Cr ₹726 Cr
Profit After Tax ₹1,127 Cr ₹902 Cr ₹751 Cr ₹583 Cr ₹689 Cr ₹545 Cr ₹662 Cr ₹589 Cr
EPS ₹42.53 ₹34.04 ₹28.34 ₹22.00 ₹26.00 ₹20.57 ₹24.98 ₹22.23
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 10.5% 18% 51.4%
SUN PHARMACEUTICAL INDUSTRIES 8.1% 9.3% 9%
TORRENT PHARMACEUTICALS 2.9% 2.1% 30.7%
CIPLA 1.4% 8.1% -6.8%
DR REDDYS LABORATORIES -0.1% 16% 14.6%
MANKIND PHARMA 4% 7.5% 5.8%
LUPIN -0.8% 2.7% 0.2%
ZYDUS LIFESCIENCES -3.2% 7.6% 21.9%
AUROBINDO PHARMA 6.3% 10% 55.2%

DIVIS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

19.35 %

Y-o-Y

35.40 %

Quarters Revenues % Change
Sep2026 ₹3,676 Cr
19.35
Jun2026 ₹3,080 Cr
8.80
Mar2026 ₹2,831 Cr
8.72
Dec2025 ₹2,604 Cr
-4.09
Sep2025 ₹2,715 Cr
12.66
Jun2025 ₹2,410 Cr
-6.77
Mar2025 ₹2,585 Cr
11.47
Dec2024 ₹2,319 Cr -

DIVIS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

24.78 %

Y-o-Y

76.35 %

Quarters Operating Profit % Change
Sep2026 ₹1,566 Cr
24.78
Jun2026 ₹1,255 Cr
34.37
Mar2026 ₹934 Cr
4.94
Dec2025 ₹890 Cr
0.23
Sep2025 ₹888 Cr
21.81
Jun2025 ₹729 Cr
-17.72
Mar2025 ₹886 Cr
19.25
Dec2024 ₹743 Cr -
Operating Margins
Q-o-Q

4.54 %

Y-o-Y

30.24 %

Quarters Operating Margin% % Change
Sep2026 42.6%
4.54
Jun2026 40.75%
23.52
Mar2026 32.99%
-3.48
Dec2025 34.18%
4.49
Sep2025 32.71%
8.13
Jun2025 30.25%
-11.73
Mar2025 34.27%
6.96
Dec2024 32.04% -

DIVIS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

24.94 %

Y-o-Y

63.57 %

Quarters Profit After Tax % Change
Sep2026 ₹1,127 Cr
24.94
Jun2026 ₹902 Cr
20.11
Mar2026 ₹751 Cr
28.82
Dec2025 ₹583 Cr
-15.38
Sep2025 ₹689 Cr
26.42
Jun2025 ₹545 Cr
-17.67
Mar2025 ₹662 Cr
12.39
Dec2024 ₹589 Cr -
PAT Margins
Q-o-Q

4.68 %

Y-o-Y

20.80 %

Quarters PAT Margin(%) % Change
Sep2026 30.66 %
4.68
Jun2026 29.29 %
10.40
Mar2026 26.53 %
18.49
Dec2025 22.39 %
-11.78
Sep2025 25.38 %
12.25
Jun2025 22.61 %
-11.71
Mar2025 25.61 %
0.83
Dec2024 25.4 % -

DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

24.94 %

Y-o-Y

63.58 %

Quarters EPS % Change
Sep2026 ₹42.53
24.94
Jun2026 ₹34.04
20.11
Mar2026 ₹28.34
28.82
Dec2025 ₹22
-15.38
Sep2025 ₹26
26.40
Jun2025 ₹20.57
-17.65
Mar2025 ₹24.98
12.37
Dec2024 ₹22.23 -

You may also like the below Video Courses